Skip to main content
. 2021 Dec 17;36(1):e24171. doi: 10.1002/jcla.24171

TABLE 2.

Correlation of lnc‐GAS5 expression with comorbidities in AIS patients

Items Lnc‐GAS5 expression Statistic (χ2 ) p value
Q1 (n = 30) Q2 (n = 30) Q3 (n = 30) Q4 (n = 30)
Hypertension, no. (%)
No 6 (20.0) 6 (20.0) 5 (16.7) 3 (10.0) 1.190 0.275
Yes 24 (80.0) 24 (80.0) 25 (83.3) 27 (90.0)
Hyperlipidemia, no. (%)
No 16 (53.3) 23 (76.7) 12 (40.0) 13 (43.3) 2.656 0.103
Yes 14 (46.7) 7 (23.3) 18 (60.0) 17 (56.7)
Hyperuricemia, no. (%)
No 19 (63.3) 17 (56.7) 18 (60.0) 17 (56.7) 0.171 0.679
Yes 11 (36.7) 13 (43.3) 12 (40.0) 13 (43.3)
Diabetes mellitus, no. (%)
No 26 (86.7) 25 (83.3) 19 (63.3) 21 (70.0) 3.977 0.046
Yes 4 (13.3) 5 (16.7) 11 (36.7) 9 (30.0)
CKD, no. (%)
No 24 (80.0) 28 (93.3) 27 (90.0) 20 (66.7) 1.935 0.164
Yes 6 (20.0) 2 (6.7) 3 (10.0) 10 (33.3)

Abbreviations: AIS, acute ischemic stroke; CKD, chronic kidney disease; Lnc‐GAS5, long non‐coding RNA growth arrest‐specific transcript 5; Q1, quartile 1.